Business Combination, Fee upon Termination of Agreement

No definition available.

Name:	indv_BusinessCombinationFeeUponTerminationOfAgreement
Namespace Prefix:	indv_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Business Combination, Share Exchange Ratio

+ References

No definition available.

+ Details

Name:	indv_BusinessCombinationShareExchangeRatio
Namespace Prefix:	indv_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Commitments To Extend Credit

+ References

No definition available.

+ Details

Name:	indv_CommitmentsToExtendCredit
Namespace Prefix:	indv_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Dividends, Common Stock, Dividend Payment Right

+ References

No definition available.

+ Details

Name:	indv_DividendsCommonStockDividendPaymentRight
Namespace Prefix:	indv_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of Individuals on Board of Directors

+ References

No definition available.

+ Details

Name:	indv_NumberOfIndividualsOnBoardOfDirectors
Namespace Prefix:	indv_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of Individuals on Board of Directors, Nominated by each Company

+ References

No definition available.

+ Details

Name:	indv_NumberOfIndividualsOnBoardOfDirectorsNominatedByEachCompany
Namespace Prefix:	indv_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Stockholders, Ownership Percentage

+ References

No definition available.

+ Details

Name:	indv_StockholdersOwnershipPercentage
Namespace Prefix:	indv_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480070/505-10-S50-1

+ Details

Name:	us-gaap_DividendsCommonStockCash
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 830
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481674/830-30-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 855
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483399/855-10-50-2

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=indv_AcquisitionTermLoanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=indv_SupernusPharmaceuticalsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=indv_SupernusPharmaceuticalsInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=indv_IndiviorStockholdersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=indv_SupernusStockholdersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	indv_SpecialDividendAxis=indv_SpecialDividendOptionOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	indv_SpecialDividendAxis=indv_SpecialDividendOptionTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Subsequent Events (Details) - Subsequent Event $ in Millions		3 Months Ended
	Aug. 01, 2026 USD ($) shares	Dec. 31, 2026 USD ($) individual
Unsecured Debt \| Acquisition Term Loan
Subsequent Event [Line Items]
Commitments to extend credit	$ 650
Supernus Pharmaceuticals, Inc.
Subsequent Event [Line Items]
Share exchange ratio \| shares	1.5401
Termination fee	$ 174
Supernus Pharmaceuticals, Inc. \| Supernus Pharmaceuticals, Inc.
Subsequent Event [Line Items]
Termination fee	$ 101
Forecast
Subsequent Event [Line Items]
Number of Individuals on Board of Directors \| individual		8
Number of individuals on Board of Directors nominated by each company \| individual		4
Forecast \| Indivior Stockholders
Subsequent Event [Line Items]
Stockholders ownership percentage		56.50%
Forecast \| Supernus Stockholders
Subsequent Event [Line Items]
Stockholders ownership percentage		43.50%
Forecast \| Supernus Pharmaceuticals, Inc. \| Special Dividend, Option One
Subsequent Event [Line Items]
Cash dividend		$ 1,000
Forecast \| Supernus Pharmaceuticals, Inc. \| Special Dividend, Options Two
Subsequent Event [Line Items]
Cash dividend		500
Dividend payment right		$ 530